This is preserved historical wording.
It is no longer the current profile. Read the canonical profile and its correction notice.
It is no longer the current profile. Read the canonical profile and its correction notice.
Update · July 27, 2026
We rewrote the profile summary to describe the cited study record more directly. The cited source and status did not change. 1
What this version reported
ClinicalTrials.gov lists a Boehringer Ingelheim study as active, not recruiting, updated July 22, 2026.↗
Organizations named in cited records:
- Boehringer Ingelheim↗
Trial records: NCT05202353
Sources for this version
- 1BI 456906 Compared With Semaglutide on Glucagon Receptor Activity in the Liver · record history version 50 · last update posted 2026-07-22 ↗
ClinicalTrials.gov · Official source · Source checked July 22, 2026